Afyx Development A/S: Financial statements 2021
CVR: 35839739
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -27,442,244 and a net result of DKK -35,049,956 compared with DKK -49,478,597 the year before. Equity in the 2021 report amounted to DKK -88,033,840. The company had 6 employees in the financial year.
- Gross Profit
- DKK -27,442,244
- Profit/Loss
- DKK -35,049,956
- Equity
- DKK -88,033,840
- Total Assets
- DKK 28,457,969
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -27.4 mio. | -35 mio. | -88 mio. | 6 |
| 2020 | - | -36.2 mio. | -49.5 mio. | -53 mio. | 10 |
| 2019 | - | -52.5 mio. | -57.7 mio. | -3.5 mio. | 10 |
| 2018 | - | -37.6 mio. | -45.1 mio. | 54.2 mio. | 8 |
| 2017 | - | -23.4 mio. | -25.6 mio. | 99.3 mio. | 3 |
Official annual report
Find more companies like Afyx Development A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Afyx Development A/S has published its annual report for 2020. Gross profit came to DKK -36,231,067, and the net result was DKK -49,478,597.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Therapeutics A/S. The company has 8 employees (2018). In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987.